Impax Laboratories Inc. v. Lannett Holdings Inc.

Procedural entryThis page is a short order in Impax Laboratories Inc. v. Lannett Holdings Inc.. Read the opinion of the Court — 893 F.3d 1372 →

Court of Appeals for the Federal Circuit·Decided July 2, 2018·No. 17-2020·Published

Opinion

United States Court of Appeals for the Federal Circuit ______________________

July 2, 2018

ERRATUM ______________________

Appeal No. 2017-2020

IMPAX LABORATORIES INC., ASTRAZENECA AB, ASTRAZENECA UK LIMITED, Plaintiffs-Appellees

LANNETT HOLDINGS INC., LANNETT COMPANY INC., Defendants-Appellants ______________________

Decided: June 28, 2018 Precedential Opinion ______________________

Please make the following change: On page 2, line 7, U.S. Patent 6,760,237 is changed to U.S. Patent 6,750,237.

Free access — add to your briefcase to read the full text and ask questions with AI

United States Court of Appeals for the Federal Circuit ______________________

July 2, 2018

ERRATUM ______________________

Appeal No. 2017-2020

IMPAX LABORATORIES INC., ASTRAZENECA AB, ASTRAZENECA UK LIMITED, Plaintiffs-Appellees

LANNETT HOLDINGS INC., LANNETT COMPANY INC., Defendants-Appellants ______________________

Decided: June 28, 2018 Precedential Opinion ______________________

Please make the following change: On page 2, line 7, U.S. Patent 6,760,237 is changed to U.S. Patent 6,750,237.

Impax Laboratories Inc. v. Lannett Holdings Inc., (Fed. Cir. 2018).

Pincite

Impax Laboratories Inc. v. Lannett Holdings Inc. (Impax Laboratories Inc. v. Lannett Holdings Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.